Semnur Pharmaceuticals, Inc. (SMNR)
OTCMKTS · Delayed Price · Currency is USD
8.00
0.00 (0.00%)
At close: Feb 23, 2026

Semnur Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22
1,8423,4463972111
Market Cap Growth
1458.34%8625.86%-45.38%-35.07%-
Enterprise Value
1,8513,45681--
Last Close Price
8.0015.0011.8810.1710.29
PB Ratio
-88.76-166.08-0.92-1.90-3.20
Debt / Equity Ratio
-0.74-0.74-1.15-0.99-1.02
Net Debt / Equity Ratio
-0.74-0.74-1.15-0.99-1.01
Quick Ratio
0.000.000.340.010.14
Current Ratio
0.060.06171.290.020.37
Return on Assets (ROA)
-2497.14%-2497.14%-79.36%-278.24%-
Return on Capital Employed (ROCE)
1818.40%1818.40%-70.50%1689.60%-664.00%
Earnings Yield
-8.71%-4.66%-11.88%-4.51%-3.38%
Buyback Yield / Dilution
-2.39%-2.39%-25.00%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.